Washington State Addiction Statistics: Updated 2026

Washington State, like many parts of the United States, has experienced a significant increase in addiction rates over the past decade. The consequences of addiction are severe, with impacts felt by individuals, families, and communities. This article will examine the causes of the rise in addiction rates in Washington State and discuss some potential solutions to address this growing problem.

Washington recorded 3,459 confirmed drug overdose deaths in 2023, the highest annual total in the state’s history and nearly triple the 1,181 recorded in 2018. Confirmed figures for 2024 show 3,145 deaths, the first decline since 2013, and opioid deaths fell again in 2025.

Those sentences describe a state whose situation changed faster than most published statistics have kept up with. This article covers what Washington’s addiction and overdose numbers actually look like now, where they came from, and what the data says about Southwest Washington specifically.

A Prevalence of Substance Abuse

According to the National Survey on Drug Use and Health, approximately 10% of Washington State residents aged 12 and older had a substance use disorder in 2018. This amounts to over 700,000 individuals grappling with addiction. Furthermore, the Substance Abuse and Mental Health Services Administration (SAMHSA) reports that Washington State ranks among the top 10 states with the highest rates of alcohol abuse, marijuana use, and illicit drug use other than marijuana. These statistics paint a disturbing picture of the extent of addiction in the state.

Causes of Rising Addiction Rates

Several factors contribute to the high rates of addiction in Washington State. Among them are:

What’s Driving Addiction Rates in Washington

No single factor explains the last seven years. These are the ones the evidence supports.

Co-occurring mental health conditions

Substance use disorders and mental health conditions frequently occur together, and each makes the other harder to treat. In Washington, an estimated 8.2% of adults had both a substance use disorder and a mental illness in the past year, roughly one adult in twelve. That is a model-based estimate averaged across 2023 and 2024, with a margin of error running from 6.9% to 9.7%.

The concentration among young adults is far sharper. For Washington adults aged 18 to 25 the estimate is 14.8%, against 7.3% for adults 26 and older. The margins of error on those two figures do not overlap, so this is a real difference rather than statistical noise. Roughly one in seven young adults in Washington is living with both conditions at once, about twice the rate of older adults.

Source: SAMHSA 2023-2024 NSDUH state prevalence estimates. These are modeled estimates for the population as a whole, not a measure of how many people with a mental illness also have a substance use disorder.

This is why treating one condition while ignoring the other tends to fail. Someone using alcohol to manage untreated anxiety, or stimulants to manage untreated depression, is solving a real problem in a way that creates a larger one. Co-occurring disorders require both conditions to be treated at the same time, by the same team.

The shift from prescription opioids to illicit supply

Washington’s prescription opioid death counts have been flat since 2018 while synthetic opioid deaths increased roughly tenfold. Prevention efforts aimed at prescribing practices address a real risk, but they no longer address where most deaths are coming from.

Counterfeit pills and unknown potency

A large share of illicit pills in circulation are counterfeit. The Drug Enforcement Administration has documented the use of pill presses to manufacture counterfeit medication laced with fentanyl or methamphetamine, sold as prescription pills. Someone who believes they are taking a familiar prescription medication may be taking an unknown quantity of fentanyl instead. There is no reliable way to identify a counterfeit pill by appearance.

Economic and access factors

Poverty, housing instability, and limited access to healthcare are all associated with higher rates of substance use disorder. The relationship is correlational rather than causal, and most people facing economic hardship do not develop a substance use disorder. But barriers to mental health care and treatment are consistently higher in lower-income communities, and those barriers affect who gets help and how early.

Solutions to Address the Addiction Problem

There is no one-size-fits-all solution to the complex issue of addiction, but several strategies have shown promise in reducing addiction rates and minimizing the negative impacts of addiction in Washington State. These include:

• Prevention and Education: One of the most effective ways to combat addiction is through prevention and education efforts. These may include school-based substance abuse prevention programs, public awareness campaigns, and parent and family education about the risks and signs of addiction.
• Access to Mental Health Services: Improving access to mental health services is critical in addressing the co-occurring disorders that often contribute to addiction. Increased funding for mental health programs, including school-based services, would allow more individuals to access the care they need and potentially reduce the likelihood of substance abuse.
• Regulating Prescription Drug Practices: Crackdowns on illegal prescription drug practices and increased oversight of prescriptions can help reduce the availability of addictive prescription medications. Additionally, increasing the availability of medications like naloxone, which reverses opioid overdoses, could save lives and curb the rates of opioid addiction.
• Drug Courts and Diversion Programs: Washington State has more than 20 drug courts that offer alternative sentencing for drug offenders. These programs focus on treatment and rehabilitation rather than punishment, providing an opportunity for individuals to address their addiction and reduce recidivism rates.
• Comprehensive Treatment Services: Access to evidence-based addiction treatment services is essential in addressing addiction rates. This includes individual and group counseling, medication-assisted treatment, and support services such as housing and employment assistance. Increased funding for treatment services and efforts to destigmatize addiction will help more individuals access the help they need to overcome their addiction.
• Harm Reduction Strategies: Efforts to minimize the negative impacts of drug use through harm reduction strategies, such as needle exchanges and safe injection sites, can help save lives and reduce the spread of infectious diseases. These strategies can also help connect individuals with resources for addiction treatment.

How Many People Die From Drug Overdoses in Washington Each Year?

The Washington State Department of Health tracks overdose deaths through death certificates. The table below shows confirmed deaths by drug type, as published in May 2025.

Confirmed overdose deaths by drug type, 2018–2024

Source: Washington State Department of Health death certificate data. 2024 figures are confirmed.

The table stops at 2024 because that is where Washington’s confirmed all-drug data currently ends. The state has not published a 2025 breakdown by drug type. Figures that do exist for 2025 and 2026 are opioid-specific, and they appear in the next section rather than here, because opioid counts and all-drug counts are not interchangeable.

In 2023, Washington ranked 10th among the 50 states and the District of Columbia for overdose death rate. The burden is not evenly distributed. Statewide, overdose deaths affected Washington’s Indigenous communities at a rate of 148 per 100,000 in 2023, more than three times the statewide rate of 41.9 that year.

What “preliminary” means in this data

Recent figures change as they are finalized, and they almost always move upward. Death certification in the United States happens county by county, and cases involving drugs take longer to classify because they require toxicology.

Washington’s 2024 numbers are a working example. The preliminary count published in May 2025 was 3,086 all-drug deaths. The confirmed count is 3,145, about 2% higher. Every drug category rose or held steady; none fell. Any figure labelled preliminary should be read as a floor.

The Department of Health also suppresses county-level counts between one and nine to protect privacy, so small counties often show no number at all.

One more thing worth knowing if you compare sources. Washington publishes overdose data through more than one system, and the totals do not always match. Death certificate counts, the state’s overdose dashboard, and CDC provisional estimates each use slightly different definitions and update on different schedules. A gap between two published figures usually reflects that, not an error.

This article uses the death certificate series throughout so the years stay comparable.

Fentanyl Has Replaced Heroin in Washington

The single largest change in Washington’s drug supply is visible in two rows of that table.

Heroin was involved in 329 deaths in 2018, and synthetic opioids in 224. By 2024, heroin accounted for 36 deaths and synthetic opioids for 2,295. Heroin did not become safer - it was displaced. Fentanyl is cheaper to produce, far more potent by weight, and easier to move, and it has almost entirely replaced heroin in the illicit supply reaching Washington.

Prescription opioids tell a similar story from the other direction. Deaths involving prescription opioids other than fentanyl were 305 in 2018 and 352 in 2024, essentially flat across seven years. The rise in Washington’s opioid deaths did not come from prescriptions. It came from the illicit synthetic supply.

Anyone still describing Washington’s crisis primarily in terms of overprescription is describing a version of the problem that ended years ago.

There is a second number worth putting next to those deaths. SAMHSA’s 2023-2024 state prevalence estimates put past-year opioid misuse in Washington at about 2.3% of people aged 12 and older, against a national estimate of about 2.9%. The margins of error on those two figures overlap, so Washington cannot be called meaningfully lower than the country. What it clearly is not is higher.

That matters, because Washington’s opioid death rate is well above the national average. Roughly the same share of people misusing opioids, and far more of them dying, points at how lethal the supply became rather than at how many people are using it. It is the clearest argument for why fentanyl test strips and naloxone matter here even for people whose use has not changed.

If you or someone in your family is using opioids of any kind, fentanyl addiction is now the relevant risk, regardless of what the drug was sold as.

Opioid Deaths in 2025 and 2026

Washington publishes opioid-specific counts faster than it finalizes the full drug-type breakdown, so the most recent picture is opioid-only. It points the same direction the 2024 figures did.

Source: Washington State Department of Health opioid overdose data. These counts cover opioid deaths only and are not comparable to the all-drug totals above.

Opioid deaths fell about 8% between 2024 and 2025, and synthetic opioid deaths fell by a similar margin. Synthetic opioids still account for roughly 92% of Washington’s opioid deaths, so the decline is a decline in fentanyl deaths rather than a shift toward a different drug.

The 2026 quarters need reading with care. Q1 at 416 is well below the 2025 quarterly average of about 573, which is a real and encouraging gap. Q2 at 290 is the most recent quarter and is substantially incomplete: recent-quarter counts are undercounts that rise as death certificates are finalized. The apparent drop between Q1 and Q2 is largely a reporting lag, not a finding, and it should not be read as a trend until those quarters are closed.

How Washington Compares to National Overdose Trends

Washington’s timeline runs behind the rest of the country, and that is the clearest way to understand the last few years.

In 2023, overdose deaths across the United States fell by roughly 5%. In Washington they rose by roughly 25%, the second-largest increase of any state, behind Alaska. Public health officials attribute the divergence largely to timing.

Fentanyl reached the Pacific Northwest later than it reached the East Coast and the Midwest. Washington entered the steep part of the curve while other states were coming down it.

The national decline since then has been substantial. The Centers for Disease Control and Prevention estimates that synthetic opioids caused 48,422 overdose deaths nationally in 2024, down from 76,282 in 2023. Washington’s decline over the same period was far smaller.

It would be easy to read 2024 as the end of the crisis, and easy to overstate the recovery in the other direction.

Washington’s 2024 decline was the first since 2013. Researchers at the University of Washington’s Addictions, Drug & Alcohol Institute recorded a rebound in the fourth quarter of 2024 that carried into the first quarter of 2025. As of their July 2026 analysis, that uptick does not appear to have continued.

County-level increases are still being flagged. ADAI identified a notable rise in Adams County in the fourth quarter of 2025, and in Asotin and Pacific Counties in the first quarter of 2026. Methamphetamine-involved deaths rose in Asotin, Pacific, and Pend Oreille. Statewide the direction is down. Locally it is uneven.

Methamphetamine and Polysubstance Deaths

Opioids dominate the coverage, but methamphetamine has risen alongside them. Deaths involving psychostimulants went from 473 in 2018 to 1,908 in 2023 and 1,851 in 2024, a nearly fourfold increase over six years.

Use appears higher here than nationally. SAMHSA estimates past-year methamphetamine use in Washington at about 1.4% of people aged 12 and older, against about 0.9% nationally. The margins of error on those two estimates overlap at the edges, so read it as a signal rather than a settled gap. Washington’s estimated rate of past-month illicit drug use, roughly 19% against about 17% nationally, points the same direction.

Most Washington overdose deaths now involve more than one substance. In 2024, 2,643 of the state’s 3,145 drug deaths involved more than one drug, about 84%. ADAI’s analysis of drug combinations shows that more than 42% of drug poisoning deaths involve both methamphetamine and synthetic opioids, and only about one in seven involve synthetic opioids alone.

This matters clinically. Someone whose primary substance is methamphetamine may still be exposed to fentanyl without knowing it. Treatment that addresses only one substance addresses only part of the picture. Effective substance use disorder treatment has had to adapt to a supply where most people are exposed to several drugs at once.

Addiction in Southwest Washington and Clark County

Most Washington statistics are reported statewide or for King County. Southwest Washington looks different from both, and the difference is large enough to be more than noise.

Clark County recorded 157 drug overdose deaths in 2024, an age-adjusted rate of 28.2 per 100,000, against a statewide rate of 37.7. The margins of error on those two figures do not overlap, so Clark County’s rate is genuinely lower than Washington’s as a whole rather than lower by chance. That was true in 2023 as well.

Put those two years side by side and a second pattern appears. Washington’s rate fell 10% between 2023 and 2024, and the margins of error on the state’s two figures do not overlap, so that decline is real. Clark County’s rate moved from 28.9 to 28.2, a change small enough that the margins of error overlap almost entirely. In statistical terms Clark County did not improve; it held steady.

So the county sits in an unusual position. Its rate is meaningfully below the state’s, and it did not share in the state’s improvement. The gap between Clark County and Washington as a whole narrowed in 2024 not because Clark got worse, but because the rest of the state got better faster.

Lower than the state is not the same as low. Clark County counted 104 deaths involving synthetic opioids in 2024, down slightly from 107 in 2023, but well above the 42 recorded in 2020. Clark County Public Health reported the first consistent decline since 2018 between 2023 and 2024, roughly 5%. Within that, methamphetamine-related deaths fell about 16% and fentanyl-involved deaths about 3%.

For drug and opioid overdose hospitalizations in 2023, Clark County sat near the middle of the state at 68.05 per 100,000, just below the statewide rate of 69.55.

Discover Recovery’s Camas, Washington location serves this corridor, including Vancouver and the surrounding Portland metro area.

Conclusion

Addressing the issue of addiction in Washington State requires a multifaceted approach that combines prevention, treatment, and harm reduction strategies. It is essential for policymakers, healthcare providers, community organizations, and individuals to work together to combat this growing problem and reduce the devastating effects of addiction on individuals, families, and communities. By understanding the causes of addiction and implementing evidence-based solutions, a healthier and more vibrant future for Washington State can be realized. Sources:

1. National Survey on Drug Use and Health 2018 report
2. Substance Abuse and Mental Health Services Administration
3. Washington State Department of Health
4. Washington State Institute for Public Policy